Stock report · Delisted · Nasdaq
Kronos Bio Inc (KRON)
0.88USD Delisted Final close · Jun 20, 2025
KRON no longer trades. Kronos Bio Inc was delisted from the Nasdaq in June 2025.
All prices on this page are historical. The last trade was on June 20, 2025, at $0.88.
KRON stock price history
Final trading statistics
- Final close
- $0.88
- Final trading day
- Jun 20, 2025
- Market cap at delisting
- $53.65M
- Shares outstanding
- 60.97M
- Final 52-week range
- $0.65 – $1.60
- Avg. volume (final 3 mo.)
- 863,209
- All-time high
- $38.23 · Nov 2020
- All-time low
- $0.67 · Jun 2025
- Return since IPO
- -96.7%
- Beta
- 1.64
- Book value / share
- $1.31
- Price / book
- 0.67
About Kronos Bio Inc
Kronos Bio was a clinical-stage biopharmaceutical company in the U.S. working on small molecule drugs for cancer and other serious illnesses. Its candidates were both p300 KAT inhibitors in preclinical development. KB-9558 targeted multiple myeloma and HPV-driven tumors, and KB-7898 targeted Sjogren's disease.
The company was incorporated in 2017 and based in San Mateo, California. As of June 20, 2025, it became a subsidiary of Concentra Biosciences, LLC. Its shares were removed from the Nasdaq in June 2025, last trading on June 20, 2025 at $0.88.
- Exchange (former)
- Nasdaq
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- San Mateo, CA
- Employees
- 8
- IPO date
- October 9, 2020
- Delisted
- June 20, 2025
- SEC CIK
- 1741830
Kronos Bio financials before the delisting
The last 5 fiscal years Kronos Bio reported as a public company, fiscal year ending December.
KRON revenue and net income
KRON earnings per share
KRON annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $9.85M | −$86.1M | −$1.22 |
| FY2023 | $6.29M | −$112.7M | −$1.95 |
| FY2022 | $3.08M | −$129.3M | −$2.37 |
| FY2021 | $0.00 | −$149.1M | −$2.75 |
| FY2020 | $0.00 | −$64.1M | −$5.25 |
Net income is GAAP. EPS is adjusted (non-GAAP) EPS, as reported.
Kronos Bio stock FAQ
What happened to Kronos Bio stock?
Kronos Bio Inc was delisted from the Nasdaq in June 2025. The final close was $0.88 on June 20, 2025.
Can I still buy KRON stock?
No. KRON is no longer listed on the Nasdaq or any other U.S. exchange; it was removed on June 20, 2025.
What was the last price of KRON?
KRON last closed at $0.88 on June 20, 2025, which valued the company at about $53.65M.
How did Kronos Bio do in its last full fiscal year?
In fiscal 2024, its last full year as a public company, Kronos Bio reported revenue of $9.85M and net income of −$86.1M.
When did Kronos Bio go public?
Kronos Bio shares started trading on October 9, 2020.
KRON no longer trades, so there is no live quote. The information on this page is for reference only and is not investment advice; see our disclaimer.